Tumor-targeted nanomedicines for cancer theranostics
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer, Clin. Cancer Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441
Northfelt, 1996, Doxorubicin encapsulated in liposomes containing surface-found polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma, J. Clin. Pharmacol., 36, 55, 10.1002/j.1552-4604.1996.tb04152.x
Abolhoda, 1999, Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin, Clin. Cancer Res., 5, 3352
Trock, 1997, Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance, J. Natl. Cancer Inst., 89, 917, 10.1093/jnci/89.13.917
Leonard, 2003, The role of ABC transporters in clinical practice, Oncologist, 8, 411, 10.1634/theoncologist.8-5-411
Hile, 2010, Persistent mobility disability after neurotoxic chemotherapy, Phys. Ther., 90, 1649, 10.2522/ptj.20090405
Rugbjerg, 2014, Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009, J. Natl. Cancer Inst., 106, 10.1093/jnci/dju110
Aleman, 2007, Late cardiotoxicity after treatment for Hodgkin lymphoma, Blood, 109, 1878, 10.1182/blood-2006-07-034405
Moses, 2003, Advancing the field of drug delivery: taking aim at cancer, Cancer Cell, 4, 337, 10.1016/S1535-6108(03)00276-9
Maeda, 2013, The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo, Adv. Drug Deliv. Rev., 65, 71, 10.1016/j.addr.2012.10.002
Bertrand, 2014, Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology, Adv. Drug Deliv. Rev., 66, 2, 10.1016/j.addr.2013.11.009
Lammers, 2012, Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress, J. Control. Release, 161, 175, 10.1016/j.jconrel.2011.09.063
Kamaly, 2012, Targeted polymeric therapeutic nanoparticles: design: development and clinical translation, Chem. Soc. Rev., 41, 2971, 10.1039/c2cs15344k
Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387
Bertrandand, 2012, The journey of a drug-carrier in the body: an anatomo-physiological perspective, J. Control. Release, 161, 152, 10.1016/j.jconrel.2011.09.098
Barenholz, 2012, Doxil®—the first FDA-approved nano-drug: lessons learned, J. Control. Release, 160, 117, 10.1016/j.jconrel.2012.03.020
Gabizon, 2003, Pharmacokinetics of pegylated liposomal doxorubicin—review of animal and human studies, Clin. Pharmacokinet., 42, 419, 10.2165/00003088-200342050-00002
Etheridge, 2013, The big picture on nanomedicine: the state of investigational and approved nanomedicine products, Nanomed. Nanotechnol., 9, 1, 10.1016/j.nano.2012.05.013
Kopecekand, 2010, HPMA copolymers: origins, early developments, present, and future, Adv. Drug Deliv. Rev., 62, 122, 10.1016/j.addr.2009.10.004
Cabraland, 2014, Progress of drug-loaded polymeric micelles into clinical studies, J. Control. Release, 190, 465, 10.1016/j.jconrel.2014.06.042
Ojha, 2015, Image-guided drug delivery: preclinical applications and clinical translation, Expert Opin. Drug Deliv., 12, 1203, 10.1517/17425247.2015.1059420
Kunjachan, 2015, Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects, Chem. Rev., 115, 10907, 10.1021/cr500314d
Radomski, 2005, Nanoparticle-induced platelet aggregation and vascular thrombosis, Br. J. Pharmacol., 146, 882, 10.1038/sj.bjp.0706386
Albanese, 2012, The effect of nanoparticle size shape, and surface chemistry on biological systems, Annu. Rev. Biomed. Eng., 14, 1, 10.1146/annurev-bioeng-071811-150124
Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol. Pharm., 5, 505, 10.1021/mp800051m
Matsumuraand, 1986, A new concept for macromolecular therapeutics in cancer-chemotherapy—mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 46, 6387
Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5
Kratzand, 2012, Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems, J. Control. Release, 164, 221, 10.1016/j.jconrel.2012.05.045
Chauhan, 2011, Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies, Annu. Rev. Chem. Biomol., 2, 281, 10.1146/annurev-chembioeng-061010-114300
Fukumuraand, 2007, Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize, J. Cell. Biochem., 101, 937, 10.1002/jcb.21187
Dreher, 2006, Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers, J. Natl. Cancer Inst., 98, 335, 10.1093/jnci/djj070
O'Brien, 2004, Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX (TM)/Doxil (R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer, Ann. Oncol., 15, 440, 10.1093/annonc/mdh097
Gordon, 2001, Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan, J. Clin. Oncol., 19, 3312, 10.1200/JCO.2001.19.14.3312
Klibanov, 1990, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett., 268, 235, 10.1016/0014-5793(90)81016-H
Harrisand, 2003, Effect of pegylation on pharmaceuticals, Nat. Rev. Drug Discov., 2, 214, 10.1038/nrd1033
Forssenand, 1994, Daunoxome® treatment of solid tumors: preclinical and clinical investigations, J. Liposome Res., 4, 481, 10.3109/08982109409037058
Rijcken, 2007, Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies, Biomaterials, 28, 5581, 10.1016/j.biomaterials.2007.08.047
Letchfordand, 2007, A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes, Eur. J. Pharm. Biopharm., 65, 259, 10.1016/j.ejpb.2006.11.009
Shi, 2015, Complete regression of xenograft tumors upon targeted delivery of paclitaxel via Pi-Pi stacking stabilized polymeric micelles, ACS Nano, 9, 3740, 10.1021/acsnano.5b00929
Letchfordand, 2012, Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics, Mol. Pharm., 9, 248, 10.1021/mp2002939
Rijcken, 2016
Talelli, 2015, Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation, Nano Today, 10, 93, 10.1016/j.nantod.2015.01.005
Park, 2016, Biodegradable inorganic nanovector: passive versus active tumor targeting in siRNA transportation, Angew. Chem. Int. Ed., 55, 4582, 10.1002/anie.201510844
Jin, 2016, Core-shell nanocarriers with high paclitaxel loading for passive and active targeting, Sci. Rep. UK, 6
Guo, 2015, Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer, Oncol. Lett., 9, 1065, 10.3892/ol.2014.2840
Liu, 2013, PEG-PLGA Nanoparticle modified by Transferrin Loading Doxorubicin: in vitro and in vivo Studies for Glioma, Adv. Mater. Res. Switz., 750–752, 1643, 10.4028/www.scientific.net/AMR.750-752.1643
Sahooand, 2005, Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention, Mol. Pharm., 2, 373, 10.1021/mp050032z
Talelli, 2013, Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy, Biomaterials, 34, 1255, 10.1016/j.biomaterials.2012.09.064
Hrkach, 2012, Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile, Sci. Transl. Med., 4, 10.1126/scitranslmed.3003651
Fiandra, 2013, Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands, ACS Nano, 7, 6092, 10.1021/nn4018922
Kirpotin, 2006, Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models, Cancer Res., 66, 6732, 10.1158/0008-5472.CAN-05-4199
Kunjachan, 2014, Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines, Nano Lett., 14, 972, 10.1021/nl404391r
Zuckerman, 2014, Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA, Proc. Natl. Acad. Sci. U. S. A., 111, 11449, 10.1073/pnas.1411393111
Senzer, 2013, Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors, Mol. Ther., 21, 1096, 10.1038/mt.2013.32
Pirollo, 2008, Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo, Clin. Cancer Res., 14, 2190, 10.1158/1078-0432.CCR-07-1951
Tolcher, 2015, Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors, J. Clin. Oncol., 33, 10.1200/jco.2015.33.15_suppl.11006
Muyldermans, 2009, Camelid immunoglobulins and nanobody technology, Vet. Immunol. Immunopathol., 128, 178, 10.1016/j.vetimm.2008.10.299
Koukourakis, 2000, High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas—rationale for combination with radiotherapy, Acta Oncol., 39, 207, 10.1080/028418600430789
Harrington, 2001, Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes, Clin. Cancer Res., 7, 243
Al-Ahmadyand, 2016, Chemical components for the design of temperature-responsive vesicles as cancer therapeutics, Chem. Rev., 116, 3883, 10.1021/acs.chemrev.5b00578
Mura, 2013, Stimuli-responsive nanocarriers for drug delivery, Nat. Mater., 12, 991, 10.1038/nmat3776
Manzoor, 2012, Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors, Cancer Res., 72, 5566, 10.1158/0008-5472.CAN-12-1683
Kiessling, 2014, Nanoparticles for imaging: top or flop?, Radiology, 273, 10, 10.1148/radiol.14131520
Baetke, 2015, Applications of nanoparticles for diagnosis and therapy of cancer, Br. J. Radiol., 88, 10.1259/bjr.20150207
Lammers, 2010, Nanotheranostics and image-guided drug delivery: current concepts and future directions, Mol. Pharm., 7, 1899, 10.1021/mp100228v
Lammers, 2012, Personalized nanomedicine, Clin. Cancer Res., 18, 4889, 10.1158/1078-0432.CCR-12-1414
de Jong, 2014, Imaging preclinical tumour models: improving translational power, Nat. Rev. Cancer, 14, 481, 10.1038/nrc3751
Kunjachan, 2013, Noninvasive optical imaging of nanomedicine biodistribution, ACS Nano, 7, 252, 10.1021/nn303955n
Terreno, 2010, Challenges for molecular magnetic resonance imaging, Chem. Rev., 110, 3019, 10.1021/cr100025t
Onuki, 2010, Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique, Biomaterials, 31, 7132, 10.1016/j.biomaterials.2010.06.008
Kokuryo, 2015, Evaluation of thermo-triggered drug release in intramuscular-transplanted tumors using thermosensitive polymer-modified liposomes and MRI, Nanomed. Nanotechnol., 11, 229, 10.1016/j.nano.2014.09.001
Negussie, 2011, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound, Int. J. Hyperthermia, 27, 140, 10.3109/02656736.2010.528140
de Smet, 2011, Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study, J. Control. Release, 150, 102, 10.1016/j.jconrel.2010.10.036
de Smet, 2013, SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound, J. Control. Release, 169, 82, 10.1016/j.jconrel.2013.04.005
Ranjan, 2012, Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model, J. Control. Release, 158, 487, 10.1016/j.jconrel.2011.12.011
van Elk, 2015, Alginate microspheres containing temperature sensitive liposomes (TSL) for MR-guided embolization and triggered release of doxorubicin, PLoS One, 10, 10.1371/journal.pone.0141626
Schleich, 2014, Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy, J. Control. Release, 194, 82, 10.1016/j.jconrel.2014.07.059